Migration notice:
On August 9th, 2025, Finsight.com market data will be renamed and migrated to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Parent Companies
Amneal Pharmaceuticals LLC
Amneal Pharmaceuticals LLC
ABS
HYC
IGC
APAC
EMEA
LATM
USOA
Issuers
TTM
Issuers
Rating Agencies
Underwriters
View League Tables
To view dynamic league tables of the top Issuers, Rating Agencies and Underwriters, please log in or create a free Finsight.com account.
Log In
AMRX
Amneal Pharmaceuticals LLC
USD 5,014m
5
1 to 1 of 1
New Issue Deal Count
Volume
Count
Month
Quarter
Year
Stacked
Grouped
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
Recent New Issue
Pulled
In Market
Priced
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
HYC
HLTH
PRCD
AMRX 2025-1 (USD 2,100m)
Amneal Pharmaceuticals LLC
JPM
USOA
Jul 24, 2025
CCY
SIZE (M)
TNR
MTY
RNK
MO
SP
FI
TYPE
BNCH
IPT
GDNC
SPRD
CPN
NIC
PRICE
ESF
7,023.000
5
-
1wv Lqgj
T1
X+
-
Ojdkdlfn
YOUD
-
NBIB+350
-
HALF+35
-
28.69000
Tranche Comments
7 cn: Comments: LVY2.1qp (nkubjsj epfu LVY1.8qp) 7cp gkp VTKX+350 qc 99.75. Khffpi 0.50%. Bqhh Bpfi 101 6u ufec gqhh;
Deal Comments
Fuzxy Xuqj Uqzx Xtgj Stjp
Use of Proceeds
Iqdff Jqgz
HYC
HLTH
PRCD
AMRX cfr (USD 600m)
Amneal Pharmaceuticals LLC
USOA
Jul 24, 2025
B&I
BWICS & Inventory
This module is available on the Professional plan.
Learn more
Upgrade Plan
TRACE
This module is available on the Professional plan.
Learn more
Upgrade Plan
Research
Log In
Missing something? Tell us.